These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9914731)

  • 1. [Thrombophilia, anticoagulant therapy and pregnancy].
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
    Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
    Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombophilia: treatment during pregnancy.
    De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
    Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
    Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
    Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventing adverse obstetric outcome in women with thrombophilia].
    Verspyck E
    Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia and the obstetric patient.
    Cleary-Goldman J; Bettes B; Robinson JN; Norwitz E; Schulkin J
    Obstet Gynecol; 2007 Sep; 110(3):669-74. PubMed ID: 17766616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
    Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
    Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
    Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.